FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
1-Year Return
6.87%
This Quarter Return
+22.44%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$261M
AUM Growth
+$30.4M
(+13%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-8.71%
Top 10 Holdings %
Top 10 Hldgs %
85.17%
Holding
28
New
8
Increased
4
Reduced
9
Closed
3
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$11.3M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$6.01M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$5.75M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$4.21M |
| 5 |
Natera
NTRA
|
$2.53M |
Top Sells
| 1 |
AKAO
Achaogen, Inc.
AKAO
|
$34.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$7.8M |
| 3 |
Editas Medicine
EDIT
|
$4.46M |
| 4 |
iRhythm Technologies
IRTC
|
$3.62M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$2.38M |
Sector Composition
| 1 | Healthcare | 49.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTX
26
Akari Therapeutics
AKTX
$26.7M
| – | – |
-9,854
| Closed | -$1.39M |
|
|
27
Editas Medicine
EDIT
$248M
| – | – |
-274,910
| Closed | -$4.46M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-63,627
| Closed | -$919K |
|